CALTABIANO STEPHEN,OHLSTEIN ELIOT,MCCALLUM STEWART
申请号：
AP201306742
公开号：
AP201306742A0
申请日:
2011.08.02
申请国别(地区):
AP
年份:
2013
代理人:
摘要：
Pharmaceutical combinations comprising a beta-3 adrenergic receptor agonist and a muscarinic receptor antagonist, and methods for their use are disclosed. Disclosed combinations include solabegron and oxybutynin. Methods of using the pharmaceutical combinations for the treatment of one or more symptoms associated with overactive bladder, for example, frequency of urgency, nocturia, and urinary incontinence, are also disclosed.
